Please assess the completion status of the following clinical trial:

Trial Title: Enhanced Detection in Glioma Excision

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Participant is willing and able to give informed consent for participation in the study.~* Male or Female, aged 18 years or above.~* Female patients are not pregnant at time of surgery.~* Patient has consented to craniotomy for suspected glioma of any type with 5-ALA infusion.~Exclusion Criteria:~• Participants are participating in another trial at time of operation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Intraoperative imaging of 5-ALA during tumour resection (Type: EXPERIMENTAL): Participants will undergo 5-ALA guided tumour resection via craniotomy with the aim of achieving maximal safe tumour resection without significant neurological deficit. On completion of tumour resection, digital images will be taken of the resection cavity under blue light using (i) an in-built camera in the operative microscope and (ii) an ultra-high sensitivity camera attached to the side arm of the operative microscope. Biopsies approximately 5x5x5mm in size will then be taken from the anterior, posterior, lateral and inferior areas of the resection cavity which were imaged. These biopsies will be analysed by histopathology to determine the presence of glioma cells.

Based on this trial design, predict the completion outcome and termination type (if applicable).